Connect with us

Hi, what are you looking for?


Pyrexar Medical Heats up Chicago at the RSNA

Pyrexar showcased their line of superficial, interstitial and deep regional hyperthermia systems for the treatment of cancer.

Salt Lake City, UT, USA, 12/12/2015 /SubmitPressRelease123/

Pyrexar Medical, leaders in thermal therapy systems, exhibited at the Radiological Society of North America (RSNA) Annual Meeting held last week in Chicago’s McCormick Place.

Pyrexar showcased their line of superficial, interstitial and deep regional hyperthermia systems for the treatment of cancer. Touted at the world’s largest medical device conference, the RSNA attracted radiology professionals from around the world.

Distributors from all over the world use the RSNA to learn about new technologies and to add devices to their product offering.  “I have been attending RSNA for over thirty years”, says Mark Falkowski, CEO at Pyrexar Medical.  “The relationships and introductions you make at the show are a very important part of our total marketing and sales strategy.” This year was no different as distributors from over 30 countries were in the Pyrexar booth vying for the hyperthermia line.

In a related conference event, Mark Dewhirst, DVM, PhD from Duke University Medical Center presented “Lessons Learned from XRT/Hyperthermia”.   In his presentation Dr. Dewhirst explained how hyperthermia compliments the ability of radiotherapy to kill cancer cells and reviewed the more than a dozen positive phase III cancer trials where hyperthermia was used in conjunction with radiotherapy.  He also provided new insights on how hyperthermia affects the process of DNA damage repair.

This was Pyrexar Medical’s first year at RSNA and space has already been reserved for next year’s conference in Boston.

Pyrexar Medical is a pioneer and worldwide market leader in the development and manufacture of innovative and highly effective thermal therapy/hyperthermia treatment systems with established distribution and support networks around the world. PYREXAR HyperThermia (PYREXAR HT) treatments, proven in multiple clinical trials over the last 30 years, increase the effective dose of ionizing radiation in solid tumors up to 3X without increasing toxicity to healthy tissue.  For more information visit our website

Social Media Tags:hyperthermia, cancer, RSNA

Newsroom powered by Online Press Release Distribution –

Like Us on Facebook

You May Also Like

Health News

The cosmetic and facial plastic surgery practice is hosting a grand opening celebration and ribbon cutting for its new Chattanooga state-of-the-art location.

Current News

“NEXT by TRT World Forum” Brought Together Globally Known Young Professionals

Current News

Merchants can now use the free get4it Competitive Analysis Tool to see the overall health of their store and inventory.


Everything You've Ever Learned About Marketing And Advertising Is Wrong. Everything You've Ever Heard, Everything You've Ever Tried, And Everything You've Ever Done Is...